Numelab | News

Chronic Lymphocytic Leukemia CLL Product release

Molecular Diagnostics

June 03, 2015

Multiplicom is pleased to announce the release of the new CLL MASTR Plus, a RUO assay for identification of mutations in the coding regions of 9 genes related to CLL.

The CLL MASTR Plus is a molecular assay for the identification of both SNVs and CNAs in 9 selected genes (listed under the specifications tab) in individuals with indication of CLL.
Multiplicom’s CLL MASTR Plus assay is provided as a ready-to-use kit that offers robust performance with minimum hands-on time. All reagents for multiplex amplification of 251 unique amplicons (261-437 bp), ensuring complete coverage of all coding sequences in 6 PCR reactions are included.
The assay is compatible with all current Massively Parallel Sequencing (MPS) systems, providing the flexibility to choose your preferred method.

Back to News Home

Improve DNA extraction from diverse soil environments

Molecular Diagnostics

It is well known that the gut microbiota contributes to health and disease. Many studies have demonstrated that external factors such as diet, geographical location and host genetics are key contributors. However, the relative contribution of these factors in shaping the gut microbiota is unclear, likely due to large interindividual variation.

February 28, 2017 More +

Simple new prenatal blood test for early and accurate detection of major chromosomal abnormalities

Molecular Diagnostics

Multiplicom is proud to launch Clarigo™, a new CE-IVD1 non-invasive prenatal test (NIPT). This highly accurate blood test will enable genetic analysis laboratories to detect the presence or absence of major chromosomal abnormalities such as trisomy 21 (Down’s syndrome), 18 (Edwards’ syndrome) and 13 (Patau syndrome), in the fetus, as early as in the first trimester of pregnancy by analysis of the fetus’s DNA in the maternal blood.

October 22, 2015 More +